RETRACTION: Effect of postoperative ischemia on steroid hormone receptors and c-erbB-2 levels in breast cancer tissue (Retraction of Vol 2, Pg 1677, 2017)

被引：0

作者：

Saydam, Mehmet ^{[1
]}

Yilmaz, Ibrahim ^{[1
]}

机构：

[1] Diskapi Yildirim Beyazit Training & Res Hosp, Dept Gen Surg, Ankara, Turkey

来源：

TURKISH JOURNAL OF SURGERY | 2018年 / 34卷 / 04期

关键词：

D O I：

10.5152/turkjsurg.2018.151118

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：351 / 351

页数：1

共 50 条

[21] Simultaneous quantitative analyses of c-erbB-2 protein, epidermal growth factor receptor, cathepsin D, and hormone receptors in breast cancer
Iwase, H
Itoh, Y
Kuzushima, T
Yamashita, H
Iwata, H
Toyama, T
Hara, Y
Kobayashi, S
CANCER DETECTION AND PREVENTION, 1997, 21 (01): : 29 - 35
[22] AMPLIFICATION OF THE C-ERBB-2 ONCOGENE IN BREAST-CANCER AND ITS RELATIONSHIP TO ESTROGEN AND PROGESTERONE RECEPTORS
TODD, DM
MILLER, JM
RUBIN, AD
DEBARI, VA
DIAGNOSTIC ONCOLOGY, 1992, 2 (06): : 313 - 317
[23] RETRACTION: TPD52L2 silencing inhibits lung cancer cell proliferation by cell cycle G2/M phase arrest (Retraction of, Vol 10, pg 9785, 2017) (Retraction of Vol 10, Pg 9785, 2017)
不详
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (01): : 413 - 413
[24] Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer
Eissa, S
Khalifa, A
ElGharib, A
Salah, N
Mohamed, MK
ANTICANCER RESEARCH, 1997, 17 (2B) : 1417 - 1423
[25] Co-expression of steroid hormone receptors (estrogen receptor α and/or progesterone receptors) and Her2/neu (c-erbB-2) in breast cancer:: Clinical outcome following tamoxifen-based adjuvant therapy
Gago, FE
Fanelli, MA
Ciocca, DR
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2006, 98 (01): : 36 - 40
[26] RETRACTION: IMPDH2 is highly expressed in breast cancer and predicts unfavourable prognosis (Retraction of Vol 51, Pg 931, 2018)
Zhao, Yueming
Yang, Yawen
Dai, Jixing
Xing, Dejun
Dong, Ying
BIOMARKERS, 2021, 26 (01) : 74 - 74
[27] Plasma c-erbB-2 levels in breast cancer patients:: Prognostic significance in predicting response to chemotherapy
Mehta, RR
McDermott, JH
Hieken, TJ
Marler, KC
Patel, MK
Wild, LD
Das Gupta, TK
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) : 2409 - 2416
[28] RETRACTION: Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver (Retraction of Vol 110, Pg 12012, 2013)
Zimmerman, Michael A.
Grenz, Almut
Tak, Eunyoung
Kaplan, Maria
Ridyard, Douglas
Brodsky, Kelley S.
Mandell, Mercedes Susan
Kam, Igal
Eltzschig, Holger K.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (26) : E5279 - E5279
[29] Serum and tissue c-erbB-2 antigen levels predicts outcome and response to hormonal therapy of bone metastatic breast cancer.
Elangovan, AE
Wilson, GH
Cramer, A
Howell, A
Anderson, E
BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 242 - 242
[30] Frequency of HER-2 (c-erbB-2) Receptors in Breast Cancer Patients and its Association with other Etiological Factors
Nisar, Bushra
Saqib, Muhammad Afzal
Ali, Asghar
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2015, 9 (04): : 1206 - 1209

← 1 2 3 4 5 →